MA45392B1 - Heterocyclic compounds used as immunomodulators - Google Patents
Heterocyclic compounds used as immunomodulatorsInfo
- Publication number
- MA45392B1 MA45392B1 MA45392A MA45392A MA45392B1 MA 45392 B1 MA45392 B1 MA 45392B1 MA 45392 A MA45392 A MA 45392A MA 45392 A MA45392 A MA 45392A MA 45392 B1 MA45392 B1 MA 45392B1
- Authority
- MA
- Morocco
- Prior art keywords
- immunomodulators
- compounds used
- heterocyclic compounds
- compounds
- alleviation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D515/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des composés de formule (i), des méthodes d'utilisation de ces composés comme immunomodulateurs, et des compositions pharmaceutiques comprenant de tels composés. Ces composés sont utiles dans le traitement, la prévention ou l’atténuation des symptômes de maladies ou de troubles tels que le cancer ou les infections.The invention relates to compounds of formula (i), methods of using these compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment, prevention or alleviation of symptoms of diseases or disorders such as cancer or infections.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662352485P | 2016-06-20 | 2016-06-20 | |
PCT/US2017/038120 WO2017222976A1 (en) | 2016-06-20 | 2017-06-19 | Heterocyclic compounds as immunomodulators |
Publications (2)
Publication Number | Publication Date |
---|---|
MA45392A MA45392A (en) | 2021-04-21 |
MA45392B1 true MA45392B1 (en) | 2022-10-31 |
Family
ID=63962960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA45392A MA45392B1 (en) | 2016-06-20 | 2017-06-19 | Heterocyclic compounds used as immunomodulators |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR108836A1 (en) |
MA (1) | MA45392B1 (en) |
-
2017
- 2017-06-19 AR ARP170101696A patent/AR108836A1/en unknown
- 2017-06-19 MA MA45392A patent/MA45392B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR108836A1 (en) | 2018-10-03 |
MA45392A (en) | 2021-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47043A1 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
MA39783A (en) | USEFUL QUINOXALINE DERIVATIVES AS FGFR KINASE MODULATORS | |
MA40290A1 (en) | Immune-regulating agents | |
MA47079A (en) | AMINO-TRIAZOLOPYIDINE COMPOUNDS AND THEIR USE TO TREAT CANCER | |
MA40111B1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
MA45020B1 (en) | Aromatic sulfonamide derivatives | |
MA40955B1 (en) | 2-amino-6- (difluoromethyl) -5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors | |
EA201992878A1 (en) | COMPOUNDS FOR TREATMENT OF HUNTINGTON'S DISEASE | |
MA38483A1 (en) | Inhibitors of ido | |
MA43169B1 (en) | Heterocyclic compounds as pi3k-gamma inhibitors | |
MA37762B1 (en) | N-aryltriazole compounds used as antagonists of lpar | |
MA37764A1 (en) | N-alkyltriazole compounds used as antagonists of lpar | |
MA38648A1 (en) | Carboxamide compounds of substituted carbazole and tetrahydrocarbazole suitable as kinase inhibitors | |
MA38810A1 (en) | Inhibitors of rorc2 related methods of use | |
MA46229B1 (en) | Heteroaryl carboxamide compounds as inhibitors of ripk2 | |
MA37765A1 (en) | Substituted pyrazole compounds used as lpar antagonists | |
MA38425A1 (en) | Bicyclic compounds for use as selective agonists for the s1p1 receptor | |
MA39253B1 (en) | Substituted bicyclic heteroaryl compounds used as rxr agonists | |
MA39524A1 (en) | 1h-1,8-naphthyridin-2-ones used as antiproliferative compounds | |
MA53372B1 (en) | Pyridopyrimidinenes as histamine h4 receptor inhibitors | |
MA45392B1 (en) | Heterocyclic compounds used as immunomodulators | |
MA44144A (en) | HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS | |
MA43263B1 (en) | Heterocyclic compounds used as immunomodulators | |
MA52220B1 (en) | Heterocyclic compounds used as immunomodulators | |
MA39533A1 (en) | Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases |